Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Is Metabolic and Bariatric Surgery a Population Solution for Obesity and Type 2 Diabetes?

Is Metabolic and Bariatric Surgery a Population Solution for Obesity and Type 2 Diabetes? Research Original Investigation Bariatric Surgery vs Medical Treatment for Type 2 Diabetes 23. Hsu CC, Chang HY, Huang MC, et al. HbA1c 28. Lakdawala M, Shaikh S, Bandukwala S, 33. Gregg EW, Chen H, Wagenknecht LE, et al; variability is associated with microalbuminuria Remedios C, Shah M, Bhasker AG. Roux-en-Y gastric Look AHEAD Research Group. Association of an development in type 2 diabetes: a 7-year bypass stands the test of time: 5-year results in low intensive lifestyle intervention with remission of prospective cohort study. Diabetologia. 2012;55 body mass index (30-35 kg/m(2)) Indian patients type 2 diabetes. JAMA. 2012;308(23):2489-2496. (12):3163-3172. with type 2 diabetes mellitus. Surg Obes Relat Dis. 34. Wing RR, Bolin P, Brancati FL, et al; Look 2013;9(3):370-378. 24. Lee WJ, Yu PJ, Wang W, Chen TC, Wei PL, AHEAD Research Group. Cardiovascular effects of Huang MT. Laparoscopic Roux-en-Y versus 29. Brethauer SA, Aminian A, Romero-Talamás H, intensive lifestyle intervention in type 2 diabetes. mini-gastric bypass for the treatment of morbid et al. Can diabetes be surgically cured? long-term N Engl J Med. 2013;369(2):145-154. obesity: a prospective randomized controlled metabolic effects of bariatric surgery in obese 35. Jüllig M, Yip S, Xu A, et al. Lower fetuin-A, clinical http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Surgery American Medical Association

Is Metabolic and Bariatric Surgery a Population Solution for Obesity and Type 2 Diabetes?

Blackstone, Robin P.
JAMA Surgery , Volume 150 (12) – Dec 1, 2015
Download PDF
2 pages

Loading next page...
 
/lp/american-medical-association/is-metabolic-and-bariatric-surgery-a-population-solution-for-obesity-9sWb3Kw2e0
Publisher
American Medical Association
Copyright
Copyright 2015 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6254
eISSN
2168-6262
DOI
10.1001/jamasurg.2015.2616
pmid
26375987
Publisher site
See Article on Publisher Site

Abstract

Research Original Investigation Bariatric Surgery vs Medical Treatment for Type 2 Diabetes 23. Hsu CC, Chang HY, Huang MC, et al. HbA1c 28. Lakdawala M, Shaikh S, Bandukwala S, 33. Gregg EW, Chen H, Wagenknecht LE, et al; variability is associated with microalbuminuria Remedios C, Shah M, Bhasker AG. Roux-en-Y gastric Look AHEAD Research Group. Association of an development in type 2 diabetes: a 7-year bypass stands the test of time: 5-year results in low intensive lifestyle intervention with remission of prospective cohort study. Diabetologia. 2012;55 body mass index (30-35 kg/m(2)) Indian patients type 2 diabetes. JAMA. 2012;308(23):2489-2496. (12):3163-3172. with type 2 diabetes mellitus. Surg Obes Relat Dis. 34. Wing RR, Bolin P, Brancati FL, et al; Look 2013;9(3):370-378. 24. Lee WJ, Yu PJ, Wang W, Chen TC, Wei PL, AHEAD Research Group. Cardiovascular effects of Huang MT. Laparoscopic Roux-en-Y versus 29. Brethauer SA, Aminian A, Romero-Talamás H, intensive lifestyle intervention in type 2 diabetes. mini-gastric bypass for the treatment of morbid et al. Can diabetes be surgically cured? long-term N Engl J Med. 2013;369(2):145-154. obesity: a prospective randomized controlled metabolic effects of bariatric surgery in obese 35. Jüllig M, Yip S, Xu A, et al. Lower fetuin-A, clinical

Journal

JAMA Surgery – American Medical Association

Published: Dec 1, 2015

References

  • Effect of bariatric surgery vs medical treatment on type 2 diabetes in patients with body mass index lower than 35: five-year outcomes [published online September 16, 2015].
    Hsu, C-C; Almulaifi, A; Chen, J-C
  • BMI cut points to identify at-risk Asian Americans for type 2 diabetes screening.
    Hsu, WC; Araneta, MR; Kanaya, AM; Chiang, JL; Fujimoto, W
  • Weight change and health outcomes at 3 years after bariatric surgery among individuals with severe obesity.
    Courcoulas, AP; Christian, NJ; Belle, SH
  • Bariatric surgery versus intensive medical therapy for diabetes: 3-year outcomes.
    Schauer, PR; Bhatt, DL; Kirwan, JP
  • Health benefits of gastric bypass surgery after 6 years.
    Adams, TD; Davidson, LE; Litwin, SE
  • Review of the key results from the Swedish Obese Subjects (SOS) trial: a prospective controlled intervention study of bariatric surgery.
    Sjöström, L
  • Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial.
    Ikramuddin, S; Korner, J; Lee, WJ
  • Cost-effectiveness of bariatric surgery for severely obese adults with diabetes.
    Hoerger, TJ; Zhang, P; Segel, JE; Kahn, HS; Barker, LE; Couper, S
  • Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States.
    Ma, RCW; Chan, JCN
  • Obesity and severe obesity forecasts through 2030.
    Finkelstein, EA; Khavjou, OA; Thompson, H
  • Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial.
    Wing, RR
  • Long-term persistence of hormonal adaptations to weight loss.
    Sumithran, P; Prendergast, LA; Delbridge, E
  • The biology and genetics of obesity: a century of inquiries.
    Jou, C
  • Paternal diet defines offspring chromatin state and intergenerational obesity.
    Öst, A; Lempradl, A; Casas, E
  • Epigenetic signatures of obesity.
    Ozanne, SE